

The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective Among its major competitors, The Medicines Company is ranked in 10th place for NPS while Alnylam Pharmaceuticals is 1st, and Biogen is 2nd.Their current market cap is $6.77B